[ad_1]
Therefore, regulators have recommended that people with significant allergic reactions to vaccines, drugs, or foods avoid vaccination. Pfizer’s clinical trials did not address such allergic reactions, according to the UK Medicines and Healthcare Products Authority (MHRA). This is because Pfizer’s clinical trials excluded those with a history of severe allergic reactions to the vaccine or its ingredients.
Allergy immunology experts at Imperial College London, advising MHRA, told Reuters they are seeking a change in recommendations to clarify that people with food allergies are not at risk. The allergic reaction could also be due to the PEG in Pfizer’s vaccine, which is an ingredient that stabilizes injections, but not in other vaccines, is not related to food allergies, and is not at risk for patients allergic to any particular medication. the expert noted.
Consequently, UK regulators also said they would review the allergy warning. In this regard, a virus and vaccination scientist at the Mayo Clinic also pointed out that if you have a history of hypersensitivity to the vaccine, you should be aware of allergic reactions.
In this regard, JP Morgan also diagnosed that in the clinical trial of the Pfizer vaccine, appendicitis was more common in the vaccination group than in the placebo group, but it is not high compared to the incidence in the general population. Meanwhile, Pfizer’s vaccine is also approved in Canada and vaccination will begin soon. In Canada, vaccination starts from the first vaccination group and is aimed at 100% vaccination for the general population starting in April next year.
Reporter Kim Ja-yeon [email protected]
<저작권자 © 의학신문, 무단 전재 및 재배포 금지>
